GNH USA

Europe — EMA

Lipoplus

GNH USA supplies Lipoplus (Omega-3-Acid Triglycerides), a parenteral lipid emulsion for patients requiring parenteral nutrition and severe malnutrition.

Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain

Request sourcing

1
Pack/s

What is Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain?

Omega-3-Acid Triglycerides, the active ingredient in Lipoplus, is a parenteral lipid emulsion presented as an intravenous emulsion for patients who cannot receive enteral feeding. It supplies essential fatty acids and calories to support nutrition in severe malnutrition, postoperative recovery, and critical illness. GNH USA supplies Lipoplus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain used for?

Lipoplus is used in clinical situations where intravenous lipid nutrition is required. - Patients requiring parenteral nutrition: provides essential fatty acids and calories when oral or enteral intake is not possible. - Severe malnutrition: helps restore energy balance and fatty acid stores in individuals with profound nutritional deficits. - Post‑operative or critically ill patients unable to receive enteral feeding: supports metabolic needs during recovery or intensive care.

What are the side effects of Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain?

Lipoplus may be associated with a range of infusion‑related reactions.

Common Side Effects: - Hypertriglyceridaemia: elevated blood triglyceride levels during therapy. - Fever or chills: transient temperature rise during infusion. - Infusion site reactions: erythema, pain, or swelling at the catheter site. - Elevated liver enzymes: mild increases in hepatic transaminases.

Serious or Rare Side Effects: - Fat overload syndrome: severe metabolic disturbance with hepatic dysfunction. - Allergic reactions: urticaria, bronchospasm, or anaphylaxis. - Thrombocytopenia: reduced platelet count in susceptible patients. - Pulmonary embolism: rare but potentially life‑threatening clot formation.

What precautions apply to Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain?

When using Lipoplus, clinicians should observe specific safety measures. - Monitor triglyceride levels: check serum triglycerides regularly to avoid hypertriglyceridaemia. - Assess liver function: perform periodic liver enzyme tests during prolonged therapy. - Observe for signs of infection: watch infusion sites for redness or discharge. - Adjust dose in renal or hepatic impairment: consider reduced infusion rates. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain interact with?

Lipoplus can interact with other agents that affect lipid metabolism or coagulation.

Major Interactions (Avoid): - Concurrent lipid emulsions: may cause excessive lipid load and fat overload syndrome. - Propofol infusion: both provide lipid calories and can precipitate hypertriglyceridaemia.

Moderate Interactions (Monitor Closely): - Warfarin or other anticoagulants: omega‑3 fatty acids may enhance anticoagulant effect. - High‑dose heparin: can further increase triglyceride levels. - Other omega‑3 supplements: risk of additive effects on bleeding time.

Frequently asked questions

What is Lipoplus used for?+
Lipoplus is an intravenous lipid emulsion used to provide essential fatty acids and calories to patients who cannot receive nutrition through the gastrointestinal tract, such as those on parenteral nutrition, with severe malnutrition, or who are post‑operative or critically ill.
How does Omega-3-Acid Triglycerides work in Lipoplus?+
Omega‑3‑acid triglycerides in Lipoplus are hydrolysed after infusion, releasing free fatty acids that become energy substrates, integrate into cell membranes, and modulate inflammatory pathways, thereby meeting the metabolic and nutritional needs of patients receiving parenteral nutrition.
What is the usual dose of Lipoplus?+
The dose of Lipoplus is individualized; the prescribing clinician determines the infusion rate and total daily amount based on the patient’s caloric requirements, lipid tolerance, and clinical condition.
Is Lipoplus safe during pregnancy or breastfeeding?+
The safety of Lipoplus in pregnancy or lactation has not been fully established. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.
How do I order Lipoplus from GNH USA?+
To order Lipoplus, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and import documentation.
How does Lipoplus compare with other parenteral lipid emulsions?+
Lipoplus contains a blend of omega‑3, soybean, and medium‑chain triglycerides, offering a balanced fatty‑acid profile that may reduce inflammation compared with traditional soybean‑only emulsions. Choice of product depends on clinical goals, patient tolerance, and institutional protocols.
What are the storage and handling requirements for Lipoplus?+
Lipoplus must be stored at 2‑8 °C, protected from light, and kept refrigerated. Do not freeze or shake the emulsion; inspect for visual changes before use and discard if the solution appears discoloured or separated.
How is Lipoplus administered?+
Lipoplus is administered intravenously as an emulsion, typically infused through a central or peripheral line over a prescribed period. Administration sets should be compatible with lipid emulsions, and infusion rates are adjusted according to the patient’s nutritional plan.
What are the most serious risks associated with Lipoplus?+
Serious risks include fat overload syndrome, severe allergic reactions such as anaphylaxis, thrombocytopenia, and rare events like pulmonary embolism. Continuous monitoring of triglyceride levels, liver function, and clinical signs is essential during therapy.
Who should not receive Lipoplus?+
Lipoplus should be avoided in patients with known hypersensitivity to any component of the emulsion, those with severe hypertriglyceridaemia, uncontrolled bleeding disorders, or in cases where a contraindication to intravenous lipid administration exists.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain
Route
Intravenous Use
Manufacturer
B.Braun Melsungen Ag
Origin
EU

Related products